Effects of beta-adrenergic agonists on bone-resorbing activity in human osteoclast-like cells

Biochim Biophys Acta. 2003 May 12;1640(2-3):137-42. doi: 10.1016/s0167-4889(03)00042-9.

Abstract

In the present study, we demonstrate for the first time that beta-adrenergic agonists stimulate bone-resorbing activity in human osteoclast-like multinucleated cells (MNCs). Osteoclast-like MNCs constitutively expressed mRNA for alpha1B-, alpha2B- and beta2-adrenergic receptor (AR) in addition to characteristic markers of mature osteoclast, such as calcitonin receptor (CT-R), tartrate-resistant acid phosphatase (TRAP), alphaV-chain of integrin (Int alphaV), carbonic anhydrase II (CA-II) and cathepsin K (Cathe K). Epinephrine (1 microM; alpha,beta-adrenergic agonist) up-regulated expression of Int alphaV, CA-II and Cathe K in the osteoclast-like MNCs. Osteoclastic resorbing activity was markedly increased by isoprenaline (1 microM; beta-adrenergic agonist), moderately by epinephrine, but poorly by phenylephrine (1 microM; alpha1-adrenergic agonist). The actin ring, which was suggested to be correlated with bone-resorbing activity, was clearly observed in osteoclast-like MNCs treated with isoprenaline and epinephrine, but faintly in those treated with phenylephrine. These findings suggest that beta-adrenergic agonists directly stimulate bone-resorbing activity in matured osteoclasts.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Agonists / pharmacology*
  • Bone Resorption / chemically induced*
  • Cells, Cultured
  • Epinephrine / pharmacology
  • Humans
  • Isoproterenol / pharmacology
  • Osteoclasts / drug effects*
  • Osteoclasts / physiology
  • Phenylephrine / pharmacology
  • RNA, Messenger / analysis
  • Receptors, Adrenergic / genetics

Substances

  • Adrenergic beta-Agonists
  • RNA, Messenger
  • Receptors, Adrenergic
  • Phenylephrine
  • Isoproterenol
  • Epinephrine